Phase III Comparison of Tamoxifen Versus Tamoxifen Plus Ovarian Function Suppression in Premenopausal Women With Node-Negative, Hormone Receptor–Positive Breast Cancer (E-3193, INT-0142): A Trial of the Eastern Cooperative Oncology Group

PURPOSE: The effects of ovarian function suppression (OFS) on survival and patient-reported outcomes were evaluated in a phase III trial in which premenopausal women were randomly assigned to tamoxifen with or without OFS. PATIENTS AND METHODS: Premenopausal women with axillary node-negative, hormon...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Clin Oncol
मुख्य लेखकों: Tevaarwerk, Amye J., Wang, Molin, Zhao, Fengmin, Fetting, John H., Cella, David, Wagner, Lynne I., Martino, Silvana, Ingle, James N., Sparano, Joseph A., Solin, Lawrence J., Wood, William C., Robert, Nicholas J.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Society of Clinical Oncology 2014
विषय:
ORIGINAL REPORTS
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4251958/
https://ncbi.nlm.nih.gov/pubmed/25349302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.55.6993
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन